Filing Details

Accession Number:
0001209191-18-016000
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-02 18:45:34
Reporting Period:
2018-02-28
Accepted Time:
2018-03-02 18:45:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301747 P Richard Bermingham 800 W. Olympic Blvd. Suite 406
Los Angeles CA 90015
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-28 7,503 $44.79 11,087 No 4 M Direct
Common Stock Disposition 2018-02-28 3,649 $92.10 7,438 No 4 D Direct
Common Stock Acquisiton 2018-02-28 4,526 $79.58 11,964 No 4 M Direct
Common Stock Disposition 2018-02-28 3,911 $92.10 8,053 No 4 D Direct
Common Stock Disposition 2018-03-02 3,800 $91.77 4,253 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-02-28 7,503 $0.00 7,503 $44.79
Common Stock Stock Appreciation Rights Disposition 2018-02-28 4,526 $0.00 4,526 $79.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-05-31 2022-05-31 No 4 M Direct
0 2016-12-19 2023-12-19 No 4 M Direct
Footnotes
  1. The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.
  2. Amount of securities beneficially owned following the reported transaction was corrected to add 1,665 shares previously disclosed on the reporting person's Form 4 filed on May 9, 2017.
  3. The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.